BACE1 and Alzheimer disease: Studies from our laboratory and others applied genetic or immunization-based approaches to demonstrate that partial reduction of BACE1 suffices to attenuate Aβ-related pathology and rescue synaptic and memory deficits in mouse models of AD [18], [19], [20], [21], [22].